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The human iron-proteome†
Claudia Andreini,ab Valeria Putignano,a Antonio Rosato ab and Lucia Banci *ab
Organisms from all kingdoms of life use iron-proteins in a multitude of functional processes. We applied
a bioinformatics approach to investigate the human portfolio of iron-proteins. We separated iron-
proteins based on the chemical nature of their metal-containing cofactors: individual iron ions, heme
cofactors and iron–sulfur clusters. We found that about 2% of human genes encode an iron-protein.
Of these, 35% are proteins binding individual iron ions, 48% are heme-binding proteins and 17% are
iron–sulfur proteins. More than half of the human iron-proteins have a catalytic function. Indeed, we
predict that 6.5% of all human enzymes are iron-dependent. This percentage is quite different for the
various enzyme classes. Human oxidoreductases feature the largest fraction of iron-dependent family
members (about 37%). The distribution of iron proteins in the various cellular compartments is uneven.
In particular, the mitochondrion and the endoplasmic reticulum are enriched in iron-proteins with
respect to the average content of the cell. Finally, we observed that genes encoding iron-proteins are
more frequently associated to pathologies than the all other human genes on average. The present
research provides an extensive overview of iron usage by the human proteome, and highlights several
specific features of the physiological role of iron ions in human cells.
Significance to metallomics
Iron is one of the most ancient and abundant metal ions in living organisms: it participates in fundamental biological processes, such as photosynthesis, and
respiration. It is an essential metal ion for humans. Here, we applied a bioinformatics approach to predict the entire set of human proteins that use iron as
cofactor. We found that about 2% of human genes encode an iron-protein. In particular, 35% are proteins binding individual iron ions, 48% are heme-binding
proteins and 17% are iron–sulfur proteins. Most of these proteins are enzymes: 37% of the human oxidoreductases need an iron ion to perform their catalytic
mechanisms. The analysis of the subcellular location highlighted that some organelles are enriched in iron-proteins, in particular about 7% of the proteins
localized in the endoplasmic reticulum and in the mitochondrion bind iron. Finally, our data show that mutations in genes encoding iron-binding proteins are
more likely to be associated with pathology than all human genes on average.
Introduction
During evolution, organisms have selected some of the avail-
able elements from the environment to catalyze physiological
reactions. Consequently, some metal ions became essential to
life. Iron is one of the most ancient and abundant transition
metal ions in living organisms,1,2 as it was highly available as
ferrous ion in the early days of terrestrial life.3 Iron is essential
to all forms of life and participates in fundamental biological
processes, such as photosynthesis, respiration and nitrogen
fixation.4,5 In cells, it is normally found in the +2 (ferrous)
and/or +3 (ferric) oxidation states. Higher oxidation states may
be generated transiently in the course of the catalytic cycle of
enzymatic reactions. Besides individual iron ions, proteins can
bind also iron-containing cofactors, such as heme or iron–sulfur
clusters.6–8 Heme is one of the most versatile prosthetic groups
in metalloproteins. The porphyrin constituting the heme group
can be of several types, including e.g. heme a, heme b, and heme c.
The heme proteins that transfer electrons mainly belong to the
cytochromes class, and may contain one or several heme groups;
globins are heme-containing proteins involved in dioxygen
binding and/or transport; other heme proteins serve as biological
sensors for oxidative stress. The broad range of possible reactions
occurring at the heme center is mainly based on the ability of the
heme iron to coordinate small molecules like CO, NO, and O2.
The protein matrix canmodulate the affinity towards the different
exogenous ligands. Iron–sulfur clusters contain two or more iron
ions bridged by sulfide ions. Each iron ion is tetracoordinated,
with its coordination sphere typically completed by the sulfur
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or nitrogen atoms of cysteine and histidine side chains, respectively.9
The metal site of rubredoxin, which contains a single iron ion
coordinated by four cysteines, is generally classified as the simplest
unit of iron–sulfur clusters. Iron–sulfur clusters are among
the most versatile inorganic cofactors.5 They are involved in a
plethora of functional processes, including aerobic as well as
anaerobic respiration, regulation of gene expression, amino
acid and nucleotide metabolism, DNA modification and repair
and tRNA modification.
Heme and iron–sulfur clusters are cofactors featuring a high
chemical complexity. Therefore, their biosynthesis as well as
the biosynthesis of the final holo-proteins containing these
cofactors involve a significant number of different protein
components, some of which are iron-binding proteins. In the
human cell, these biosynthetic processes have multiple pathways,
related also to cellular compartmentalization. Nevertheless, some
components may move across different compartments; further-
more, the various pathways can communicate with one another
via the exchange of biosynthetic intermediates.
While iron is essential for life, it can catalyze the formation
of potentially toxic reactive oxygen species (ROS). This process
is unavoidable in the present oxygen-rich environment, and
iron and ROS are increasingly recognized as important initia-
tors and mediators of cell death in various organisms as well as
in pathological conditions in humans.10 Therefore, biological
systems must control iron metabolism by providing the
adequate amount of iron for proper cellular function while
limiting iron toxicity.11,12 Iron has also a role in pathogen
virulence. The growth of microbial pathogens within the host
usually requires iron as an essential nutrient.13,14 Heme-
containing proteins, such as hemoglobin, and transferrin are
the preferential iron sources for human pathogens.15,16 There-
fore, another crucial reason for the cell to maintain a strict
control on iron homeostasis is to restrict its access by pathogens.
In this paper, we carried out a systematic prediction of iron-
binding proteins encoded in the human genome, extending our
previous analysis on iron–sulfur proteins.17 By integrating this
prediction with information on heme and individual iron ions, we
achieved a complete landscape of the iron handling by proteins in
human, thus providing a framework for the understanding of
physiological iron metabolism and of its dysfunction in diseases.
Results
Iron binding by human proteins and their coordination
spheres
We analysed iron usage by human proteome via three different
possible modes of binding: as individual iron ions, as iron-
containing heme cofactors and as iron–sulfur clusters. In total,
we identified 398 human genes whose protein products interact
with iron (iron-proteins hereafter), i.e. about 2% of the human
genes. Of these, 139 genes express proteins binding individual
iron ions (Table S1, ESI†), 192 express proteins binding heme
(Table S2, ESI†) and 7017 express proteins binding iron–sulfur
clusters (Table S3, ESI†).
The coordination spheres of the three different iron-
containing cofactors are quite diverse; we refer to the pattern
of the protein residues coordinating the iron ion(s) of the
cofactor as the iron-binding pattern (IBP). The IBP is a regular
expression defined by the identity of the amino acids coordi-
nating the metal and by their spacing along the protein
sequence (e.g. CX4CX25C). Thus, the coordination sphere of
each iron ion corresponds to a single IBP.
In IBPs of human iron-proteins binding individual iron ions,
histidine is by far the most common residue. His is present in
94% of these IBPs, each of which contains on average two His
(Fig. 1). Aspartate, glutamate and tyrosine are found in 53%,
30% and 10% of the identified patterns, respectively. On
average, only one Asp and one Tyr are found in each IBP,
whereas there can be one (such as in most iron-dependent
enzymes) or two (such as in ferritins) Glu residues. All iron–
sulfur binding proteins use on average three-four cysteines to
coordinate the cluster. Cys is absolutely required in the IBPs of
these proteins. In particular, in human iron–sulfur proteins the
coordination sphere of the Fe4S4 clusters is always and only
composed by cysteines whereas the IBPs of Fe2S2 clusters
sometimes (37% of Fe2S2 IBPs) include one or two His residues.
In human heme-binding proteins, IBPs commonly contain one
or two His with the exception of catalytic heme sites (such as in
cytochrome P450) where Cys is more common (83% of IBPs).
The function of the metal cofactor within the protein is
correlated also to the number of coordinating residues provided
by the protein (i.e. the number of residues in the IBP).
Fig. 1 Analysis of the first coordination sphere for the predicted iron-
proteins; (A) percentage of patterns containing a specific residue for
different iron cofactor types. (B) Average occurrence of a specific residue
within patterns, for each iron cofactor.
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Indeed, the coordination sphere of the metal ion is not always
completed by atoms of the protein. 64% of the sites that bind
individual iron ions contain three protein residues in the IBP,
whereas the others contain four protein residues. Similarly,
most of the iron ions in heme cofactors have only one ligand
provided by the protein (about 58%), which allows the sub-
strate to occupy the second heme axial position. The remain-
ing 42% heme sites have two coordinating residues provided
by the protein. In iron–sulfur proteins, the most common
number of protein ligands is 4; however, all the iron–sulfur
clusters that perform a catalytic function have only three Cys
ligands in the IBP. It is thus evident that there is a trend for
human iron-proteins to have a lower number of residues in
their IBPs when the metal-binding site performs a catalytic
function, in order to allow the iron ion to coordinate directly
to the substrate as already observed for other metal containing
proteins.18
Subcellular localization of human iron-proteins
We then analysed the subcellular localization of the human iron-
proteins identified through our search (Tables S4–S6, ESI†). This
information is not available for 94 proteins (37 binding individual
iron ions, 10 binding iron–sulfur clusters, and 47 binding hemes),
which were thus ignored for this analysis. Various proteins
are present in more than one compartment, and thus were
included in the statistics of each relevant organelle. Fig. 2
summarizes the distribution of the different types of iron-
proteins within each cellular compartment and reports the
fraction of iron-proteins with respect to the total number of
proteins localized in each compartment (percentages within
parenthesis). It appears that two subcellular locations stand out
for their enrichment in iron-proteins: the mitochondrion and
the endoplasmic reticulum.
Our dataset (iron-proteins for which cellular localization is
known) is composed by 45% heme-binding proteins, 34%
proteins binding individual iron ions, and 21% proteins bind-
ing iron–sulfur clusters. From Fig. 2, we can readily identify
compartments that differ appreciably in the distribution of the
types of iron-proteins. The nucleus is highly depleted of heme-
binding proteins, whereas it features a relatively high number
of proteins binding individual iron ions. On the other hand,
the mitochondrion is the compartment most enriched in
iron–sulfur proteins, with respect to both the two other types,
whereas the endosome is mostly enriched in heme-binding
proteins and does not contain any iron–sulfur protein. In
addition, the endoplasmic reticulum is enriched in heme-
binding proteins and depleted in iron–sulfur proteins. The
distribution of the three types of iron-proteins in the cytoplasm
closely resembles that of the overall dataset. It should be noted
that in this respect, we are referring to the number of proteins
and not to their relative quantity, which depends on their
expression levels. We did not analyze such levels in this work.
The mitochondrion and the endoplasmic reticulum are the
compartments with the largest percentage of iron-proteins.
As mentioned, the mitochondrion is significantly enriched in
iron–sulfur proteins (about 2.5 times the average fraction for
the whole cell), whereas the endoplasmic reticulum is enriched
in heme-binding proteins (1.6 times the cell average). The
nucleus is the only compartment where proteins binding
individual iron ions are the majority of iron-proteins (1.7 times
the cell average).
Functional roles
Fig. 3 shows the functional roles of sites binding iron and iron-
containing cofactors in human proteins (Tables S4–S6, ESI†).
This information is not available for 24 proteins (14 binding
iron–sulfur clusters, and 10 binding heme), which were thus
ignored for this analysis. It appears that sites binding heme or
individual iron ions most commonly have a catalytic role, i.e.
are directly involved in enzymatic mechanisms. This is also the
most common role for the entire set of iron-proteins, partly
due to the low number of iron–sulfur proteins. For sites
binding individual iron ions the only other relevant function
is its use as a substrate, i.e. in storage and transport processes
Fig. 2 Distribution of iron-proteins in different cellular organelles of the human cell (heme-proteins: blue; iron–sulfur proteins: grey; individual iron
ions: orange).
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(this classification of sites is taken from the MetalPDB
database9). Heme-binding sites have the largest variety of
functional roles, among which electron transfer is the second
most common. As it is well known, human heme-binding
proteins also play a crucial role in the transport of molecular
dioxygen and in sensing, particularly of small gaseous molecules
such as NO, leading to a regulatory function. Heme-binding pro-
teins associated with a substrate function (i.e. when the heme
cofactor is the target/substrate of the protein) are involved in the
biosynthesis, transport and degradation of the heme cofactor. This
may be linked also to the fact that there are as many as seven
different types of heme cofactors in human heme-binding proteins
(heme a, b, c, d, i, o, m). While the most common type is heme b,
occurring in 90% of the heme-proteins, the synthesis of all the other
heme types requires the action of specific enzymes that modify the
cofactor and/or the protein binding it (e.g. cytochrome c19).20,21 The
most common role for iron–sulfur proteins is transport, bio-
synthesis and insertion into the final target proteins of the
clusters themselves (tagged as substrate).22–26 This is the result
of both the chemical complexity of the iron-containing clusters,
thus requiring elaborate biosynthetic and degradation pathways,
and the potential toxicity of free iron ions. The second most
common roles for iron–sulfur proteins are structural and
regulatory. The role of iron–sulfur clusters in several DNA- and
RNA-binding proteins is not completely understood, in particu-
lar for the many systems involved in DNA repair, where the
presence of the cluster could be instrumental to detect lesions.
Curiously, sites performing electron transfer are less common.
We then checked whether there is a relationship between
cellular localization and protein function in order to rationalize
the patterns reported in Fig. 2. To do this we examined the lists
of the iron-proteins localized to the various compartments and
identified all the processes, as defined by the Gene Ontology
(GO27,28), associated with the corresponding genes. Seven
processes involve 81% of the genes coding for iron-proteins
localized to the endoplasmic reticulum (Table 1). The process
involving more iron-proteins is lipid metabolism, which is a key
cellular role played by cytochromes P450; only one tenth of the
genes involved in lipid metabolism codes for proteins binding
individual iron ions. Xenobiotic metabolic process and drug
metabolism are common processes which involve exclusively
heme-binding proteins and are essentially associated to cyto-
chromes P450, which are involved in the modification of
exogenous molecules, from drugs to pollutants. Proteins bind-
ing individual iron ions are involved in different pathways,
such as peptidyl amino acid hydroxylation. These pathways
do not involve any heme-binding protein. Overall, 92% of the
iron-proteins localized to the endoplasmic reticulum are oxido-
reductases, as directly observed from their Enzyme Commission
(EC) numbers, and these are either members of the cytochrome
P450 family (heme-containing enzymes) or iron-dependent
hydroxylases (typically harboring two iron ions in their active
site). The functional role of the iron-proteins in the endoplasmic
reticulum is thus tightly linked to their catalytic activity, most
commonly in biosynthetic or metabolic processes.
In the nucleus, 5 processes involve about 89% of the iron-
proteins present in this cell compartment. Gene expression is
the process associated to most of these proteins, because
several genes encode iron-proteins involved in the regulation
of transcription e.g. through DNA binding or histone modifica-
tion. Many iron-proteins in the nucleus are also involved in
Fig. 3 Distribution of the functions of the iron centers for different iron
cofactor types.
Table 1 Number of genes coding for iron-proteins in the endoplasmic
reticulum, nucleus and mitochondrion. Note that the same gene can
contribute to more than one process in each compartment. Processes
are taken from the GO annotations of all iron-protein genes
All iron_ion iron_heme iron_sulfur
Endoplasmic reticulum
Drug metabolism 14 0 14 0
Peptidyl amino acid hydroxylation 6 6 0 0
Lipid metabolic process 43 5 38 0
Cell proliferation 12 4 8 0
Response_to_stress 9 0 9 0
Vitamin metabolism 8 0 8 0
Xenobiotic metabolic process 20 0 20 0
Nucleus
Cell death/apoptotic process 20 10 5 5
Gene expression 46 33 9 4
Cell proliferation 20 11 5 4
Peptidyl amino acid hydroxylation 8 8 0 0
Response to stress 25 9 6 10
Mitochondrion
Cell death/apoptotic process 13 4 5 4
Iron ion homeostasis 11 4 4 3
Iron sulfur cluster biosynthesis 6 0 0 6
Cellular respiration 18 1 7 10
Response to drug 9 1 5 3
Response to stress 16 3 5 8
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response to stress, for instance by repairing damaged DNA, in
apoptosis17 and in cell proliferation. About half of the nuclear
iron-enzymes are oxydoreductases; transferases and hydrolases
are relatively common.
In the mitochondrion, 6 processes involve about 63% of all
iron-proteins within this cellular compartment. The process
involving the largest number of iron-proteins is cellular respira-
tion, which leverages both heme-binding and iron–sulfur pro-
teins (6 vs. 10 genes, respectively). Other processes involving
more than 10 genes are cell death, iron ion homeostasis and
response to stress (which is mainly response to oxidative
stress), half of which are iron–sulfur proteins. The biosynthesis
of iron–sulfur clusters comprises genes encoding require iron–
sulfur proteins. At the functional level, the observed enrich-
ment of the mitochondrion in iron–sulfur proteins (Fig. 2) is
largely accounted for by the involvement of these proteins in
the respiratory chain, in stress response and in the assembly of
iron–sulfur clusters themselves. For the latter, the clusters are
transiently bound by various proteins along the biosynthetic
pathway, also depending upon the final target for cluster
insertion.25,26,29 The electron transfer capabilities of iron–
sulfur proteins are important but not the only determinant of
the higher abundance in the mitochondrion of iron–sulfur
proteins with respect to all iron-proteins.
Uncharacterized putative human iron-proteins
Our analysis identified several proteins that had not been
described in the literature as binding iron or iron-containing
cofactors. In particular, Retinoid-related Orphan Receptors-
alpha, beta and gamma (RORa, RORb, and RORg, hereafter)
were predicted to have a heme-binding site similar to that
found in REV-ERBa and REV-ERBb. The REV-ERB family binds
heme with two axial ligands: one His and one Cys.30 The
sequence alignment of these two families (Fig. S1, ESI†) clearly
shows that the His ligand is strictly conserved also in the ROR
family whereas the Cys ligand is not. However, the super-
imposition of the heme-containing 3D structure of REV-ERBb
(PDB code 3CQV30) with the experimental structures of RORa,
RORb and RORg (PDB codes 1N83,31 1NQ7,32 4WLB,33 respec-
tively) shows that the latter contain a Cys (Cys323, Cys262 and
Cys320, respectively) that is essentially in the same position as
the heme-binding Cys384 of REV-ERBb (Fig. 4A). A small
rearrangement of the side chains of the Cys residues would
bring their Sg atoms at a distance from the iron ion compatible
with the formation of a coordination bond. This Cys corre-
sponds to a strictly conserved position in the multiple sequence
alignment of the ROR family (Fig. S1, ESI†). Furthermore, the
cavities of the 3D structures of ROR are sterically compatible
with the binding of a heme molecule and the regions in contact
with the cofactor have a high sequence similarity with the
REV-ERB family. Another new putative heme-binding protein
is the extracellular matrix protein FRAS1. This protein is in the
plasma membrane: it has a very long region exposed in the
extracellular matrix and a short cytoplasmatic tail. We identi-
fied three putative heme-binding sites in the extracellular part.
We predicted the occurrence of a site with two potential axial
ligands (His2080 and His3301) whereas for the other two sites,
we predicted only one ligand, i.e. His1799 and His1945, respec-
tively. The structure of this protein is not available and we were
not able to build a 3D structural model, which would have
allowed us to evaluate the possible geometrical features of the
three predicted sites. The HSPB1-associated protein 1 is another
potential iron-binding protein which could bind a single iron ion
via its residues His175, Asp177 and His257; all these three
residues are highly conserved in the protein family. For this
protein we could identify a suitable template in the PDB for 3D
structural prediction by homology modeling: the Hypoxia-
inducible factor 1-alpha inhibitor which has a sequence iden-
tity to human HSPB1-associated protein 1 as high as 26%, and
contains a site binding a single iron ion. The structural model
in Fig. 4B, shows that the predicted ligands of HSPB1-associated
protein 1 have the proper spatial configuration to bind an iron ion.
Finally, we predicted as putative heme-binding protein the phos-
phatidylinositol 3,4,5-trisphosphate 5-phosphatase 2. A structure
as well as a suitable 3D template for the putative heme-binding
region of this protein are not available. This prediction, however,
appears less reliable than the previous ones.
Pathogenic alterations associated to human iron-proteins
To assess the impact of the iron-proteome on the human
health, we investigated how often defects or mutations affect-
ing genes encoding iron-proteins are associated to pathologies
(Tables S4–S6, ESI†). We analysed only proteins in the Swiss-
Prot database (Reviewed proteins)34 and excluded those from
the trEMBL database, which are just predicted and do not have
mutational studies associated. Thus, we took into account 385
proteins (137 binding individual iron ions, 178 binding heme,
and 70 binding iron–sulfur clusters). Of these, 148 are related
to one or more pathogenic mutations or alterations, corres-
ponding to about 38% of the total. Interestingly, if we consider
the different types of iron sites, we found that more than half of
the identified iron–sulfur proteins are involved in pathologies
(37/70 corresponding to 53%). For proteins binding individual
iron ions or heme cofactors, the percentage of proteins
Fig. 4 (A) Superposition of RORa (pdb code: 1n83, in blue) and REV-ERB
(pdb code: 3cqv, in red). Only the relative positions of the putative ligands
of RORa and the iron ligands of REV-ERB are reported. The side chain of
Cys 323 is rotated to bring it closer to the heme iron. In this configuration
the distance between the potential sulfur donor and the iron ion is 3.4 Å.
(B) Putative iron-binding site in the structural model of HSPB1-associated
protein 1.
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associated to pathologies is 31% (i.e. 43/137) and 38% (i.e. 68/178),
respectively. As of January 2018, the total number of human
proteins in the Swiss-Prot database was 20259. Of these, 4014
are associated to pathogenic mutations, corresponding to about
20% of the dataset. It thus appears that on average defects or
mutations affecting genes encoding iron-proteins are more com-
monly associated to pathologies than all the other genes.
In Table 2 we broke down the cumulative data reported in
the previous paragraph for the whole human cell by looking at
specific compartments. In particular, we took into considera-
tion the compartments with the highest number of iron-
proteins. In the mitochondrion, 36% of all proteins are
associated to pathologies, whereas as many as 60% of mito-
chondrial iron-proteins are disease-related, with the main
contribution of heme-proteins and iron–sulfur proteins. Similarly,
in the cytoplasm and in the nucleus, heme-proteins and iron–
sulfur proteins are more commonly associated to pathologies
than all other human genes (Table 2).
Discussion
398 human genes encode iron-proteins, which correspond to
about 2% of all human genes. This number should be regarded
as a lower limit because within our approach to the identifi-
cation of iron-proteins false positives (i.e. proteins that do not
bind iron but are predicted to do so) are quite unlikely to occur.
This is due to the fact that we rely significantly on the known
3D structures of iron-proteins, while in the absence of structural
data we scan the literature for supporting evidence. On the other,
it is possible that we did not detect completely uncharacterized
iron-proteins, especially if they are membrane-associated. There-
fore, this number (398) should be taken as a lower limit even if
we foresee that the actual number should not be much different.
Of the 398 human iron-proteins, 48% are heme-binding
proteins, 35% are proteins binding individual iron ions and
17% are iron–sulfur proteins. The intracellular distribution of
these proteins is uneven, with some organelles containing a
larger share of iron-proteins than others do. In particular, 7%
of all the proteins localized in the endoplasmic reticulum and in
the mitochondrion are iron-proteins. Thus these two organelles are
significantly enriched (in comparative terms) in iron-proteins with
respect to the average of the entire human cell (2%, as mentioned
above). Within heme-binding proteins, 90% bind heme b and 61%
are membrane-associated.
The three types of iron-proteins feature highly diverse
preferences in the coordination sphere of the bound iron ions
(i.e. IBPs). Cys is always present in the IBPs of iron–sulfur
proteins, whereas it is practically absent from the coordination
sphere of individual iron ions. Conversely, His, which is nearly
always present in the IBPs of proteins binding individual iron
ions, is observed rarely in the IBPs of iron–sulfur proteins.
Asp is the second most common ligand in proteins binding
individual iron ions. Heme-proteins have a similar preference
for His and Cys in their IBPs. Cys is particularly common in the
IBPs of heme-proteins that have catalytic function. This is
presumably linked to the role of Cys in promoting the heterolytic
breakage of the O–O bond of the iron-bound peroxide inter-
mediate that forms along the catalytic cycle of cytochromes P450
or of nitric oxide synthase.35–37 This feature is independent of
the overall protein fold, and is defined by the coordination
chemistry properties of the sites.
6.5% of the human enzymes are iron-proteins. Unsurprisingly,
this percentage is not the same for all enzyme classes. In
particular, 37% of human oxidoreductases use a catalytic iron
ion. 56% of all human iron-proteins have a catalytic function
(Fig. 3). Proteins that bind individual iron ions mainly represent
them: 86% of these proteins (119 out of 139) are iron-dependent
enzymes. The large majority of these enzymes are oxidoreduc-
tases, in particular dioxygenases, where the iron ion is directly
involved in the transfer of electron from/to the substrate. Also,
about half of the heme-sites in the human proteins have a
catalytic function. These enzymes are primarily members of
the human cytochrome P450 family, whose isoforms are signifi-
cantly differentiated in terms of expression but have typically
broad and overlapping substrate specificities.
Iron-binding enzymes are commonly located in the nucleus
and cytoplasm, followed by the mitochondrion and endoplasmic
reticulum. The latter features the highest number of heme-
binding proteins as it is the most common localization for
cytochromes P450. Consistently with this, we observed that
processes such as drug metabolism, lipid metabolism or xeno-
biotic stimulus are the most common processes associated with
iron-proteins localized to the endoplasmic reticulum (Table 1).
In the mitochondrion, 63% of all iron-proteins are involved in
only 6 processes; the process involving the largest number of
iron-proteins is respiration, which leverages both heme-binding
and iron–sulfur proteins. The mitochondrion is the most likely
localization for iron–sulfur proteins (Fig. 2), whose primary
processes within this compartment are, besides respiration,
the biosynthesis of iron–sulfur clusters and the response to
oxidative stress. The biosynthesis of iron–sulfur clusters is
among the most common functional roles of iron–sulfur pro-
teins at the level of the whole cell,17,38 owing to the chemical
Table 2 Number of proteins associated to at least one pathology in UniProt and their ratio with respect to the total number of iron proteins in each
cellular compartment, and compared with the data for all human proteins. The percentage of disease-related proteins is in parentheses
Heme Individual iron-ions Iron–sulfur clusters Total iron-proteins All human proteins
Cytoplasm 13/27 (48%) 10/34 (29%) 8/19 (42%) 31/80 (39%) 1413/5569 (25%)
Endoplasmic reticulum 15/60 (25%) 9/17 (53%) 0/3 (0%) 24/80 (30%) 362/1163 (31%)
Mitochondrion 20/28 (72%) 5/15 (33%) 23/37 (62%) 48/80 (60%) 420/1174 (36%)
Nucleus 7/17 (41%) 10/52 (19%) 11/20 (55%) 28/89 (31%) 1180/5389 (22%)
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complexity of this group of cofactors. Within the nucleus, iron-
proteins are largely involved in various aspects of the regulation
of protein expression, such as histone modification. In addition,
also DNA binding, DNA biosynthesis and DNA replication
involve several iron-proteins, especially iron–sulfur proteins.
We identified three human members of the retinoid-related
orphan receptor (ROR) family as potentially harbouring a
heme-binding site similar to those observed in proteins of the
REV-ERB family. In the absence of experimental evidence in the
literature, our hypothesis is supported by the strict conserva-
tion of the two potential heme ligands. The experimental
structures of RORa, RORb, and RORg, feature a His and a
Cys residue in a spatial position corresponding to His and
Cys ligands of iron in REV-ERBb. Another putative human iron-
binding protein is the HSPB1-associated protein 1. A structural
model of this proteins shows that the reciprocal position in 3D
space of the putative ligands is completely consistent with our
prediction (Fig. 4).
As an important aspect of the present study, we analysed
how many pathologies are associated to human genes encoding
iron-proteins, based on the occurrence of disease-associated
mutations reported in the Swiss-Prot database. The percentage
of pathologies associated to genes encoding iron-proteins is
almost 40%, which is higher than the percentage of pathologies
associated to all human genes (about 20%). In practice, two
genes out of 10 are associated with pathogenic mutations in the
human genome, whereas this percentage is essentially doubled
if we take into account specifically the genes encoding iron-
proteins. Interestingly, this percentage peaks at 72% for all
heme-binding proteins in the mitochondrion.
In summary, this work provided an extensive overview of
iron usage by human proteins, spanning from iron coordination
properties to biochemical/cellular function and compartmenta-
lization, and addressing the interplay between these aspects. We
observed that the distribution of the type of iron cofactors and of
their catalytic properties is quite uneven, with some organelles
such as the mitochondrion or the nucleus displaying higher
occurrence than the others. The main localization of iron-
dependent enzymes, which constitute 6.5% of all human
enzymes, is the endoplasmic reticulum, where they catalyze
the modification of both endo- and exogenous molecules and
metabolites. Human iron-enzymes have a lower number of
protein residues in their IBPs, in order to allow the iron ion to
coordinate directly to the substrate.
Materials and methods
Proteins are generally composed of one or more functional
regions, commonly termed domains. The identification of
domains that occur within proteins can therefore provide
insights into their function. Pfam is a database of protein
domains, defined on the basis of the comparison of ensembles
of protein regions that share a significant degree of sequence
similarity, thereby suggesting homology. Each domain is repre-
sented by a multiple sequence alignment and by a more
complex mathematical representation called a hidden Markov
model (HMM). HMMs can be used for analyzing proteomes to
search for occurrences of the corresponding domain (see below).
Each domain entry in the Pfam database has an annotation,
which may include the ability to bind metal cofactors.
Using the approach described in ref. 39 as implemented in
the RDGB program,40 we predicted all iron-binding proteins
(IBPs) encoded by the human genome. RDGB is a computa-
tional tool written in Python. The approach of RDGB exploits
the protein domains of the Pfam database to identify putative
homologues of the proteins of interest in any desired genome
or list of genomes. Thus, the input to RDGB is a list of Pfam
domains of interest (in our case, domains associated with
iron-binding capability) and a list of genomes to be analyzed
(in our case only the human genome).
The input list of Pfam domains is created by merging two
lists: first, the list of all Pfam domains annotated as iron-
binding, retrieved by mining the text of the annotations in
the database; second, from the analysis of the sequence of iron-
binding proteins with known 3D structure that are available
from the Protein Data Bank (PDB). In the latter case, we extract
from the PDB database also the pattern of amino acids that are
responsible for metal binding (i.e. the metal binding pattern,
MBP) and its position within the domain sequence. The MBP is
defined by the identity and spacing of the amino acids, e.g.,
CX4CX20H, where X is any amino acid. This pattern provides a
way to filter the initial results in order to reduce the number of
false positives39 (i.e., of the proteins containing a Pfam domain
annotated as iron-binding but which in reality are unable to
bind it) by rejecting the proteins that lack the MBP or that have
the MBP in the wrong position within the domain. The MBP
filter cannot be applied in the absence of a relevant 3D
structure available from the PDB. The MetalPDB database
contains information on all the MBPs and the Pfam domains
found in structurally characterized metalloproteins.9 Our
search started from 352 Pfam domains: 261 with an associated
iron-containing 3D structure (102 binding individual iron ions,
80 binding iron–sulfur clusters, and 79 binding heme) and
91 annotated as iron-binding domains.
This search was integrated by locally searching from MBPs
within all human protein sequences. This is done by extracting
from the HMM representing the Pfam domain that contains the
binding site of interest only the regions around the MBP. This
‘‘trimmed domain’’ provides a convenient way to search for a
MBP regardless of the agreement with the whole Pfam domain,
thus affording a better sensitivity in the detection of MBPs in
divergent sequences.41
In total we retrieved 363 human iron-proteins. As a qualita-
tive indicator of reliability of our dataset, we checked whether
one of the following conditions applied (in decreasing order of
reliability):
(1) A 3D structure of the human protein in the iron-bound
form is available (105 proteins).
(2) A 3D structure of a close homolog (sequence identity
Z50%) of the human protein in the iron-bound form is
available (76 proteins).
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(3) The predicted protein contains an iron-binding Pfam
domain with a conserved MBP (147 proteins).
(4) The predicted protein contains a conserved MBP (based
on local search) (22 proteins).
(5) The predicted protein contains an iron-binding Pfam
domain, but the occurrence of the MBP cannot be verified due
to the lack of a 3D structure for that domain family (13 proteins).
We integrated these predictions by adding the proteins
annotated in the Uniprot database, a public comprehensive
resource of protein sequence and functional information, as
‘‘iron-binding’’, ‘‘iron–sulfur-binding’’, or ‘‘heme-binding’’.
This contributed 35 additional iron-proteins.
For each predicted iron-protein, we retrieved the following
annotations from UniProt:42 intracellular location, EC number,
biological processes as reported in the Gene Ontology database,43
involvement in diseases. Further annotation such as the cofactor
role and type were manually added by inspecting the literature.
We used the Swiss-Prot database (at February 2018 contained
20259 entries)34 to compare the iron-protein dataset with all
human proteins. For the latter dataset, annotations were retrieved
from Uniprot in the same way as for the iron-protein dataset.
The 3D structural model of the HSPB1-associated protein 1
was built using MODELER v.9.244 and energy-refined using the
AMBER45 web server provided by the WeNMR platform.46
Abbreviations
IBP Iron-binding pattern
ROS Reactive oxygen species
ROR Retinoid-related orphan receptor
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